GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (BUE:PFE) » Definitions » Shiller PE Ratio

Pfizer (BUE:PFE) Shiller PE Ratio : 5.24 (As of Apr. 28, 2024)


View and export this data going back to . Start your Free Trial

What is Pfizer Shiller PE Ratio?

As of today (2024-04-28), Pfizer's current share price is ARS6902.50. Pfizer's E10 for the quarter that ended in Dec. 2023 was ARS1,317.20. Pfizer's Shiller PE Ratio for today is 5.24.

The historical rank and industry rank for Pfizer's Shiller PE Ratio or its related term are showing as below:

BUE:PFE' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.34   Med: 17.48   Max: 24.28
Current: 9.35

During the past years, Pfizer's highest Shiller PE Ratio was 24.28. The lowest was 9.34. And the median was 17.48.

BUE:PFE's Shiller PE Ratio is ranked better than
89.56% of 517 companies
in the Drug Manufacturers industry
Industry Median: 24.4 vs BUE:PFE: 9.35

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pfizer's adjusted earnings per share data for the three months ended in Dec. 2023 was ARS-433.200. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ARS1,317.20 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pfizer Shiller PE Ratio Historical Data

The historical data trend for Pfizer's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Shiller PE Ratio Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.89 17.21 23.38 17.14 10.60

Pfizer Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.14 13.21 12.63 11.69 10.60

Competitive Comparison of Pfizer's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Pfizer's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Shiller PE Ratio falls into.



Pfizer Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pfizer's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=6902.50/1317.2
=5.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Pfizer's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-433.2/129.4194*129.4194
=-433.200

Current CPI (Dec. 2023) = 129.4194.

Pfizer Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 5.709 99.695 7.411
201406 7.312 100.560 9.410
201409 7.072 100.428 9.114
201412 3.249 99.070 4.244
201503 6.703 99.621 8.708
201506 7.633 100.684 9.811
201509 6.394 100.392 8.243
201512 -0.777 99.792 -1.008
201603 14.312 100.470 18.436
201606 9.227 101.688 11.743
201609 6.563 101.861 8.339
201612 4.122 101.863 5.237
201703 15.725 102.862 19.785
201706 16.818 103.349 21.060
201709 16.472 104.136 20.471
201712 77.144 104.011 95.989
201803 23.776 105.290 29.225
201806 32.422 106.317 39.467
201809 50.783 106.507 61.708
201812 -5.279 105.998 -6.445
201903 53.162 107.251 64.151
201906 79.529 108.070 95.241
201909 152.119 108.329 181.734
201912 -7.173 108.420 -8.562
202003 74.483 108.902 88.516
202006 84.890 108.767 101.008
202009 38.605 109.815 45.497
202012 16.276 109.897 19.167
202103 154.938 111.754 179.429
202106 185.671 114.631 209.623
202109 277.695 115.734 310.531
202112 119.168 117.630 131.112
202203 294.199 121.301 313.889
202206 416.342 125.017 431.004
202209 419.629 125.227 433.679
202212 291.711 125.222 301.490
202303 383.247 127.348 389.481
202306 196.800 128.729 197.856
202309 -293.958 129.860 -292.962
202312 -433.200 129.419 -433.200

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pfizer  (BUE:PFE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pfizer Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pfizer's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (BUE:PFE) Business Description

Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (BUE:PFE) Headlines

From GuruFocus

Pfizer Inc's Dividend Analysis

By GuruFocus Research 01-24-2024

Pfizer Inc To Host Investment Analysts Call Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Pfizer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Pfizer Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Pfizer Inc to Discuss Climate Action Transcript

By GuruFocus Research 01-23-2024